Molecular Markers of Early Pancreatic Cancer

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018

Cancer Statistics, 2005

Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186

Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., Cavallini, G., Ammann, R., Lankisch, P. G., Andersen, J. R., DiMagno, E. P., Andrén‐Sandberg, Å., & Domellöf, L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305203282001 · Cited by 1,753

Phases of Biomarker Development for Early Detection of Cancer

Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686

Colorectal carcinoma antigens detected by hybridoma antibodies

Koprowski, H., Steplewski, Z., Mitchell, K. F., Herlyn, M., Herlyn, D., & Fuhrer, P. (1979) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01542654 · Cited by 1,360

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily

Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G., Bansal, M., He, X. Y., Zhang, H. P., Donnellan, M., Mahler, S. M., Pryor, K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11514 · Cited by 1,180

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M. E. M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., & Kern, S. E. (1994) · Nature Genetics · doi:10.1038/ng0994-27 · Cited by 1,132

An Illustrated Consensus on the Classification of Pancreatic Intraepithelial Neoplasia and Intraductal Papillary Mucinous Neoplasms

Hruban, R. H., Takaori, K., Klimstra, D. S., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., Biankin, S. A., Compton, C., Fukushima, N., Furukawa, T., et al. (2004) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000126675.59108.80 · Cited by 1,091

Hereditary Pancreatitis and the Risk of Pancreatic Cancer

Lowenfels, A. B., Maisonneuve, P., DiMagno, E. P., Elitsur, Y., Gates, L. K., Perrault, J., Whitcomb, D. C., & International Hereditary Pancreatitis Study Group (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.6.442 · Cited by 988

Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

Yeo, C. J., Cameron, J. L., Lillemoe, K. D., Sitzmann, J. V., Hruban, R. H., Goodman, S. N., Dooley, W. C., Coleman, J., & Pitt, H. A. (1995) · Annals of Surgery · doi:10.1097/00000658-199506000-00011 · Cited by 945

Immunotherapy a New Hope for Cancer Treatment: A Review

Rouz, F. N., Shirkhoda, M., Memari, F., Dana, H., Chalbatani, G. M., Mahmoodzad, H., Samarghand, N., Gharagozlo, E., Mohammadi, M. H., Maleki, A. R., et al. (2018) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2018.135.150 · Cited by 25

Carbohydrate markers of pancreatic cancer

Szajda, S. D., Waszkiewicz, N., Chojnowska, S., & Zwierz, K. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390340 · Cited by 25

Identification of novel therapeutic target genes and pathway in pancreatic cancer by integrative analysis

Hu, B.-L., Cheng, S., Jiang, H., & Qin, S. (2017) · Medicine · doi:10.1097/md.0000000000008261 · Cited by 25

Neutrophil Gelatinase-Associated Lipocalin, Macrophage Inhibitory Cytokine 1, and Carbohydrate Antigen 19-9 in Pancreatic Juice

Kaur, S., Baine, M. J., Guha, S., Ochi, N., Chakraborty, S., Mallya, K. B., Thomas, C. S., Crook, J. E., Wallace, M. B., Woodward, T. A., et al. (2012) · Pancreas · doi:10.1097/mpa.0b013e31826a8597 · Cited by 24

Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma

Pietrasz, D., Sereni, E., Lancellotti, F., Pea, A., Luchini, C., Innamorati, G., Salvia, R., & Bassi, C. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01745-2 · Cited by 25

Natural Death in the Forensic Setting

Christiansen, L. R., & Collins, K. (2007) · American Journal of Forensic Medicine & Pathology · doi:10.1097/01.paf.0000233553.19938.a0 · Cited by 23

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

Prinz, C., Fehring, L., & Frese, R. (2022) · Cells · doi:10.3390/cells11152374 · Cited by 22

Human pancreatic cancer progression: an anarchy among CCN-siblings

Banerjee, S. K., Maity, G., Haque, I., Ghosh, A., Sarkar, S., Gupta, V. G., Campbell, D. R., Hoff, D. D. V., & Banerjee, S. (2016) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-016-0343-9 · Cited by 21

Scope of Artificial Intelligence in Gastrointestinal Oncology

Goyal, H., Sherazi, S. A. A., Mann, R., Gandhi, Z., Perisetti, A., Aziz, M., Chandan, S., Kopel, J. J., Tharian, B., Sharma, N. R., et al. (2021) · Cancers · doi:10.3390/cancers13215494 · Cited by 22

Current Screening Strategies for Pancreatic Cancer

Vaněk, P., Urban, O., Zoundjiekpon, V., & Falt, P. (2022) · Biomedicines · doi:10.3390/biomedicines10092056 · Cited by 21

Increased circulating cell signalling phosphoproteins in sera are useful for the detection of pancreatic cancer

Takano, S., Sogawa, K., Yoshitomi, H., Shida, T., Mogushi, K., Kimura, F., Shimizu, H., Yoshidome, H., Ohtsuka, M., Kato, A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605734 · Cited by 21

Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment

Peters, M. L. B., Tseng, J. F., & Miksad, R. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.03.006 · Cited by 21

Modeling Texture in Deep 3D CNN for Survival Analysis

Chaddad, A., Sargos, P., & Desrosiers, C. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.3025901 · Cited by 23

Early detection of pancreatic cancer by liquid biopsy “PANLIPSY”: a french nation-wide study project

Bardol, T., Dujon, A. M., Taly, V., Dunyach‐Remy, C., Lavigne, J., Costa‐Silva, B., Kurma, K., Eslami‐S, Z., Cayrefourcq, L., Canivet, C., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-12463-8 · Cited by 22

A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer

Smith, J. P., Harms, J. F., Matters, G. L., McGovern, C. O., Ruggiero, F. M., Liao, J., Fino, K. K., Ortega, E. E., Gilius, E. L., & Phillips, J. A. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.13.3.18698 · Cited by 19

The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer

Luo, K., Wang, X., Zhang, X., Liu, Z., Huang, S., & Li, R. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.933645 · Cited by 18

Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN

Li, Y., Zhang, D., LIN, D.-Q., & Cao, L. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4224 · Cited by 18

Pancreatic Cancer Biomarker Detection By Two Support Vector Strategies for Recursive Feature Elimination

Wang, Y., Liu, K., Ma, Q., Tan, Y., Du, W., Lv, Y., Tian, Y., & Wang, H. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2018-0273 · Cited by 18

Prospective Markers for Early Diagnosis and Prognosis of Sporadic Pancreatic Ductal Adenocarcinoma

Tobi, M., Kim, M., Weinstein, D. H., Rambus, M. A., Hatfield, J. S., Adsay, V. N., Levi, E., Evans, D. B., Lawson, M. J., & Fligiel, S. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2387-x · Cited by 18

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients

Zhong, A., Qin, R., Qin, W., Han, J., Gu, Y., Zhou, L., Zhang, H., Ren, S., Lu, R., Guo, L., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00114 · Cited by 18

Aldehyde dehydrogenase 1A1 and gelsolin identified as novel invasion-modulating factors in conditioned medium of pancreatic cancer cells

Walsh, N., Dowling, P., O’Donovan, N., Henry, M. A., Meleady, P., & CLYNES, M. M. (2008) · Journal of Proteomics · doi:10.1016/j.jprot.2008.09.002 · Cited by 18

Measurement of serum PODXL concentration for detection of pancreatic cancer

Taniuchi, K., Tsuboi, M., Sakaguchi, M., & Saibara, T. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s155367 · Cited by 17

Proteostasis Dysregulation in Pancreatic Cancer

Arpalahti, L., Haglund, C., & Holmberg, C. I. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_4 · Cited by 17

Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer

Ren, C., Chen, H., Han, C., Jin, G., Wang, D., Wang, D., & Tang, D. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.03.027 · Cited by 17

Pancreas-specific protein disulfide isomerase has a cell type-specific expression in various mouse tissues and is absent in human pancreatic adenocarcinoma cells: implications for its functions

Fu, X., Dai, X., Ding, J., & Zhu, B. T. (2009) · Journal of Molecular Histology · doi:10.1007/s10735-009-9230-5 · Cited by 16

Postresection Surveillance for Pancreatic Cancer Performance Status, Imaging, and Serum Markers

O'Reilly, E. M., & Lowery, M. A. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182758e27 · Cited by 15

Mining the Human Proteome

Yang, J., Roy, R., Jedinak, A., & Moses, M. A. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000139 · Cited by 15

Exploiting the MUC5AC Antigen for Noninvasive Identification of Pancreatic Cancer

Henry, K. E., Shaffer, T. M., Mack, K. N., Ring, J., Ogirala, A., Klein‐Scory, S., Eilert-Micus, C., Schmiegel, W., Bracht, T., Sitek, B., et al. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.256776 · Cited by 14

Adjuvant Treatment Strategies for Pancreatic Cancer

Newman, E. A., Simeone, D. M., & Mulholland, M. W. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.10.018 · Cited by 14

IL24 and its Receptors Regulate Growth and Migration of Pancreatic Cancer Cells and Are Potential Biomarkers for IL24 Molecular Therapy.

Jia, Y., Ji, K., Ji, J., Hao, C., Ye, L., Sanders, A. J., & Jiang, W. G. (2016) · PubMed · Cited by 12

Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer

Raja, A., Malik, M. F. A., & Haq, F. U. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252344 · Cited by 13

Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.

Gu, J., Wang, D., Huang, Y. F., Lü, Y., & Peng, C. (2014) · PubMed Central · Cited by 13

Significance of microRNA-based biomarkers for pancreatic cancer.

Kaur, S., Krishn, S. R., Rachagani, S., & Batra, S. K. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.10.32 · Cited by 13

Novel potential biomarkers for pancreatic cancer – A systematic review

Litman‐Zawadzka, A., Łukaszewicz‐Zając, M., & Mroczko, B. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.02.004 · Cited by 13

K-rasMutational Status in Cytohistological Tissue as a Molecular Marker for the Diagnosis of Pancreatic Cancer: A Systematic Review and Meta-Analysis

Yang, J., Li, J., Zhu, R., Zhang, H., Zheng, Y., Dai, W., Wang, F., Shen, M., Chen, K., Cheng, P., et al. (2014) · Disease Markers · doi:10.1155/2014/573783 · Cited by 12

LITAF is a potential tumor suppressor in pancreatic cancer

Zhou, Y., Huang, J., Yu, X., Jiang, X., Shi, Y., Weng, Y., Kuai, Y., Lei, L., Ren, G., Feng, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23220 · Cited by 12

Pancreatic cancer biomarker detection using recursive feature elimination based on Support Vector Machine and large margin distribution machine

Lv, Y., Wang, Y., Tan, Y., Du, W., Liu, K., & Wang, H. (2017) · International Conference on Systems and Informatics (ICSAI) · doi:10.1109/icsai.2017.8248514 · Cited by 12

Intraductal papillary mucinous neoplasm to pancreas ductal adenocarcinoma sequence and pancreas cancer screening

Farrell, J. (2018) · Endoscopic Ultrasound · doi:10.4103/eus.eus_49_18 · Cited by 12

The Clinical Significance of Pancreatic Steatosis in Pancreatic Cancer: A Hospital-Based Study

Chan, C.-H., Chang, C.-C., & Peng, Y. (2024) · Diagnostics · doi:10.3390/diagnostics14192128 · Cited by 11

Case Report: Anlotinib combined with PD-1 inhibitor and sequential GA regimen or FOLFIRINOX Chemotherapy in treatment of KRAS G12V mutated pancreatic ductal adenocarcinoma with liver metastasis: A case and literature review

Wang, Y., Wang, B., Xiang, L., Deng, J., Xu, B., He, P., Pu, W., Wang, H., Fan, Y., & Chen, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016647 · Cited by 9

Use of Precision Imaging in the Evaluation of Pancreas Cancer

Korn, R. L., Rahmanuddin, S., & Borazanci, E. H. (2019) · Cancer treatment and research · doi:10.1007/978-3-030-16391-4_8 · Cited by 11

Aberrantly DNA Methylated-Differentially Expressed Genes in Pancreatic Cancer Through an Integrated Bioinformatics Approach

Sun, H., Xin, R., Zheng, C., & Huang, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.583568 · Cited by 11

Comparison of platelet-lymphocyte ratio and CA 19-9 in differentiating benign from malignant head masses in patients with chronic pancreatitis

Kakkat, S., Rajan, R., Sindhu, R. S., Bonny Natesh, P., & Raviram, S. (2017) · Indian Journal of Gastroenterology · doi:10.1007/s12664-017-0768-y · Cited by 10

Pancreatic adenocarcinoma

Eskander, M. F., Bliss, L. A., & Tseng, J. F. (2016) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2016.01.001 · Cited by 10

Clinical impact of radiotherapy for locally advanced pancreatic cancer

Sawaki, A., Hoki, N., Ito, S., Matsumoto, K., Mizuno, N., Hara, K., Takagi, T. J., Kobayashi, Y., Sawai, Y., Kawai, H., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0116-9 · Cited by 10

Molecular Imaging with MRI: Potential Application in Pancreatic Cancer

Chen, C., Wu, C. Q., Chen, T. W., Tang, M. Y., & Zhang, X. M. (2015) · BioMed Research International · doi:10.1155/2015/624074 · Cited by 9

Proteomics of Cancer of Hormone-Dependent Tissues

Tyson, D. R., & Ornstein, D. K. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_9 · Cited by 9

Identification of genes and candidate agents associated with pancreatic cancer

Wang, B., Liu, Z., Sun, S., & Zhao, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-1009-3 · Cited by 9

Derivation and validation of a preoperative prognostic model for resectable pancreatic ductal adenocarcinoma

Xu, S., Zhang, X., Zhao, G., Zou, W.-B., Zhao, Z., Liu, Q., Hu, M., & Liu, R. (2022) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2022.09.009 · Cited by 8

Confirmation of a potential biomarker for early-stage pancreatic cancer1

Topilow, A. A., Davis, J. M., Vernick, J. J., Tang, D., Corbett, S., Veltman, T., Wagner, S., & Gilvarg, C. (2012) · Cancer Biomarkers · doi:10.3233/cbm-2012-0225 · Cited by 7

Cell-Free DNA for the Detection of Pancreatic, Liver and Upper Gastrointestinal Cancers: Has Progress Been Made?

Gall, T., Frampton, A. E., Krell, J., Habib, N. A., Castellano, L., Stebbing, J., & Jiao, L. R. (2013) · Future Oncology · doi:10.2217/fon.13.152 · Cited by 7

Advancing frontline early pancreatic cancer detection using within-class feature extraction in FTIR spectroscopy

Tang, Z., Duckworth, E., Mora, B., Sarireh, B. A., Mortimer, M., & Roy, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-79153-0 · Cited by 5

Blood-Based Biomarkers in the Diagnosis and Risk Stratification of Pancreatic Cysts

Peller, M. T., & Das, K. K. (2023) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2023.03.009 · Cited by 5

Early Detection of Pancreatic Cancer

Schwingel, J., Decker, M., Schneider, L., Stürmer, C. J., & Lutz, M. P. (2023) · Oncology Research and Treatment · doi:10.1159/000530790 · Cited by 5

Proteomanalyse

Löhr, M. J., Faissner, R., Findeisen, P., & Neumaier, M. (2006) · Der Internist · doi:10.1007/s00108-006-1634-7 · Cited by 5

Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer

Sha, M., Kunduzi, B., Froghi, S., Quaglia, A., Davidson, B. R., & Fusai, G. (2022) · JGH Open · doi:10.1002/jgh3.12848 · Cited by 4

Comparative analysis of leptin and carcinoembryonic antigen-related cell adhesion molecule 1 plasma expression in pancreatic cancer and chronic pancreatitis patients

Gheorghe, G., Diaconu, C. C., Mambet, C., Bleoţu, C., Ionescu, V., & Diaconu, C. C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37410 · Cited by 5

Pathological and prognostic role of mdig in pancreatic cancer

Kumar, S., Thakur, C., Li, L., Cui, H., & Chen, F. (2017) · Genes & Cancer · doi:10.18632/genesandcancer.149 · Cited by 4

An integrated computational biology approach defines the crucial role of TRIP13 in pancreatic cancer

Dhasmana, S., Dhasmana, A., Rios, S., Enriquez, I., Khan, S., Afaq, F., Haque, S., Manne, U., Yallapu, M. M., & Chauhan, S. C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.029 · Cited by 4

Pancreatic Cancer Insights: Optimization of the Diagnostic Capacity of Tumor Biomarkers

Delgado, J. A., Vizoso, M. A. B., Parera, M. M., & Bauçà, J. M. (2021) · Laboratory Medicine · doi:10.1093/labmed/lmab016 · Cited by 4

Molecular Imaging of Pancreatic Cancer in a Preclinical Animal Tumor Model Using Targeted Multifunctional Nanoparticles. Gastroenterology 2009;136:1514-1525

Cho, Y. S. (2009) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2009.53.6.388 · Cited by 4

Biomarkers in Cancer

Roy, R., Coticchia, C. M., Yang, J., & Moses, M. A. (2010) · Biomarkers · doi:10.1002/9780470918562.ch14 · Cited by 4

Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum

Peterka, O., Jirásko, R., Dolečková, Z., Dosoudilová, M., Bártl, J., Idkowiak, J., Slavíček, O., Pešková, K., Vošmik, M., Mohelníková-Duchoňová, B., et al. (2026) · Communications Medicine · doi:10.1038/s43856-026-01445-5 · Cited by 3

Integrated Analysis of Cell-Free DNA and Novel Protein Biomarkers for Stratification and Therapy Monitoring in Stage IV Pancreatic Cancer: A Preliminary Study

Hussung, S., Hess, M. E., Haghighi, E. B., Wittel, U. A., Boerries, M., & Fritsch, R. (2024) · Diagnostics · doi:10.3390/diagnostics15010049 · Cited by 3

Serum CA19-9 in patients with solid pancreatic mass.

Baghbanian, M., Baghbanian, A., Salmanroghani, H., & Shabazkhani, B. (2013) · Gastroenterology and hepatology from bed to bench. · Cited by 3

Molecules and markers for endosonographers: What do we need to know and measure?

Al‐Haddad, M., & Wallace, M. B. (2006) · Endoscopy · doi:10.1055/s-2006-946652 · Cited by 3

An enzymatic bionanotransduction system for multianalyte biological detection

Branen, J. R., Hass, M. J., Maki, W. C., & Branen, A. L. (2007) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2007.03300.x · Cited by 3

Molecular Detection and Diagnosis of Cancer

Patriotis, C., Maruvada, P., & Srivastava, S. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_41 · Cited by 3

Incorporating Molecular Oncology into Prognosis

Liu, G. G., Zhou, W., Wang, Z., & McLeod, H. L. (2006) · TNM Online · doi:10.1002/0471463736.tnmp49 · Cited by 3

Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis

Wu, D., Du, Z., Wang, Y.-C., Zheng, Y. Z., Qi, H.-M., Zhu, Y.-R.-C., Yu, C., Wang, L., Zou, W., & Liao, Z. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102674 · Cited by 2

Combating Cancer Using Nanomaterials: Development and Challenges

Husain, S., Shaw, S., Bose, S. K., & Nayak, R. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_45-1 · Cited by 2

A Morphological and Immunohistochemical Study of the Tumoral and Inflammatory Cells in Pancreatic Ductal Adenocarcinoma

Herlea, V., Stoica-Mustafa, E., Iorgescu, A., Pechianu, N., Crețoiu, D., Sajin, M., Dima, S., Vasilescu, C., Stroescu, C., Ungureanu, C., et al. (2020) · Journal of Immunology Research · doi:10.1155/2020/6148286 · Cited by 2

Screening for pancreatic ductal adenocarcinoma in the population with diabetes

Sharp, P. S., Brown, B., & Price, H. C. (2021) · Practical Diabetes · doi:10.1002/pdi.2319 · Cited by 2

Proteomics in Pancreatic Cancer Translational Research

Pan, S., Chen, R., & Brentnall, T. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-408103-1.00009-1 · Cited by 2

Latest developments in chemotherapy for metastatic pancreatic cancer

Khan, A. K., Jain, A. G., Afridi, S., Wazir, M., Rao, J. S., & Ahmad, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00006-2 · Cited by 2

Development of Novel Pancreatic Tumor Biomarkers

Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_50 · Cited by 2

Current trends in the diagnosis of pancreatic cancer

Vaněk, P., Eid, M., Psár, R., Zoundjiekpon, V., Urban, O., & Kunovský, L. (2022) · Vnitřní lékařství · doi:10.36290/vnl.2022.076 · Cited by 2

Squeezing data from pancreatic juice

Tomlinson, C. R., & Korc, M. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3486 · Cited by 2

Translation of Recent Advances and Discoveries in Molecular Biology and Immunology in the Diagnosis and Treatment of Pancreatic Cancer

Albo, D., Farrow, B. J., & Berger, D. H. (2008) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2007.12.004 · Cited by 2

Combinational Treatment for Pancreatic Cancer: Where Are We Standing?

Albrecht, A. M., Yang, J., & Li, M. (2012) · Journal of Clinical & Experimental Oncology · doi:10.4172/2324-9110.1000e103 · Cited by 1

In-depth quantitative proteomics for pancreatic cancer biomarker discovery

Faça, V. M., & Hanash, S. (2007) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.1.1.81 · Cited by 1

Pancreatic Cancer

Harris, D. M., Champaneria, M. C., & Go, V. L. W. (2006) · Elsevier eBooks · doi:10.1016/b978-012088393-6/50081-6 · Cited by 1

Metabolic Biomarkers of Pancreatic Cancer

Mahajan, U. M., Li, Q., Kamlage, B., Lerch, M. M., & Mayerle, J. V. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_5 · Cited by 1

Treatment of Pancreatic Cancer using Gemcitabine-loaded Superparamagnetic Iron Oxide Nanoparticles (SPIONs)

Nandi, S. (2020) · University of Liverpool · doi:10.17638/03102507 · Cited by 1

Identification of Potential Common Molecular Factors of Pancreatic Cancer and Diabetes Mellitus using Microarray Data Analysis Combined with Bioinformatics Techniques and Experimental Validation

Kalantari, S., Pourshams, A., Roudi, R., Zali, H., Bandehpour, M., Kalantari, A., Ghanbari, R., D’Angelo, A., Kazemi, B., & Madjd, Z. (2021) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_122_21 · Cited by 1

Screening for Pancreatic Cancer: Current Status and Future Directions

Puri, A., Chang, J. C. S., & Kundranda, M. N. (2017) · European Medical Journal · doi:10.33590/emj/10313242 · Cited by 1

Microsatellite Analysis in Serum DNA as a Diagnostic Tool for Distinction of Patients With Unknown Pancreatic Masses

Wachowiak, R., Kaifi, J. T., Schwarzenbach, H., Yekebas, E. F., Merkert, P., Schurr, P., Hansen, B., Reichelt, U., Strate, T. G., Pantel, K., et al. (2007) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e31803c9c62 · Cited by 1

Survival After Medical and Surgical Treatment of Pancreatic Adenocarcinoma

Tseng, J. F., Castillo, C. F.-D., & Warshaw, A. L. (2008) · Springer eBooks · doi:10.1007/978-3-540-28656-1_67

Select Population-Based and Translational Research for Improving Pancreatic Cancer Early Detection

Urayama, S. (2014) · InTech eBooks · doi:10.5772/57531

Clinical, Laboratory, and Radiologic Presentation of Pancreatic Cancer

Hijioka, S., & Yamao, K. (2015) · doi:10.1002/9781118307816.ch4

Pancreatic Cancer Genomics, Epigenomics, and Proteomics

Goggins, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-69252-4_12

Molecular analysis-based diagnosis for pancreatic cancer and its clinical implication

Ohuchida, K., Ohtsuka, T., Mizumoto, K., & Tanaka, M. (2010) · Suizo · doi:10.2958/suizo.25.23

miRNAs as Cancer Biomarkers

Sauter, E. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8444-8_6

Genomic Alterations in Sporadic Pancreatic Cancer

Molin, M. D., & Maitra, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6549-2_1

The role of palladin in pancreatic cancer

Stack, C. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/f3gq-dp32

Pancreatic Cancer with Normal CA 19-9 and Lewis Antigen Negative—Case Report

Mariano, R. C., Ponde, N. F., Eiger, D., Taranto, P., Segatelli, V., Pezzutti, D., & Gansl, R. C. (2017) · Journal of Pharmacy and Pharmacology · doi:10.17265/2328-2150/2017.03.005

CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis

Italia, S.-V. (2014)

Mucins in pancreatic cancer and its

Sushil Kumar, K., Momi, N., & Batra, S. K. (2013)

The Proteasome-associated deubiquitinase UCHL5/UBH-4 in proteasome modulation and as a prognostic marker in gastrointestinal cancers

Arpalahti, L. (2018) · Työväentutkimus Vuosikirja

Identifying Molecular Markers for the Early Detection of Pancreatic Neoplasia

Goggins, M. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.05.003 · Cited by 96

[Towards the identification of new markers of pancreatic cancer by gene expression analysis].

Rosty, C. (2004) · PubMed · Cited by 7

Diagnostic and Therapeutic Response Markers

Lennon, A. M., & Goggins, M. (2009) · Springer eBooks · doi:10.1007/978-0-387-77498-5_28 · Cited by 13

Expression Profiling of Pancreatic Ductal Adenocarcinoma

Iacobuzio–Donahue, C. A., & Hruban, R. H. (2003) · doi:10.1007/978-1-59259-386-6_14 · Cited by 1

Early diagnosis of pancreatic cancer

Xu, L., & Xiaozhong, G. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.3969/j.issn.1001-5256.2016.05.008